Zhejiang Huahai Pharmaceutical Co., Ltd. (SHA:600521)

SHA:600521 Revenue

In the year 2025, Zhejiang Huahai Pharmaceutical had annual revenue of 8.59B CNY, down -10.06%. Zhejiang Huahai Pharmaceutical had revenue of 2.18B in the quarter ending December 31, 2025, a decrease of -5.28%.

• Revenue: 8.59B
• Revenue Growth: -10.06%
• P/S Ratio: 2.78
• Revenue / Employee: 947.29K
• Employees: 9,065
• Market Cap: 23.84B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	8.59B	-960.28M	-10.06%
Dec 31, 2024	9.55B	1.24B	14.91%
Dec 31, 2023	8.31B	42.97M	0.52%
Dec 31, 2022	8.27B	1.62B	24.42%
Dec 31, 2021	6.64B	158.36M	2.44%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Apr 30, 2026

Data Sources Report a data error